139 related articles for article (PubMed ID: 35332440)
1. Preparation and Evaluation of Novel Supersaturated Solid Dispersion of Magnolol : Theme: Advancements in Amorphous Solid Dispersions to Improve Bioavailability.
Zhao J; Gao P; Mu C; Ning J; Deng W; Ji D; Sun H; Zhang X; Yang X
AAPS PharmSciTech; 2022 Mar; 23(4):97. PubMed ID: 35332440
[TBL] [Abstract][Full Text] [Related]
2. Amorphous solid dispersion preparation via coprecipitation improves the dissolution, oral bioavailability, and intestinal health enhancement properties of magnolol.
Cao J; Zhang S; Hao Y; Fan K; Wang L; Zhao X; He X
Poult Sci; 2023 Jun; 102(6):102676. PubMed ID: 37104903
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
Shen H; Liu S; Ding P; Wang L; Ju J; Liang G
J Pharm Pharmacol; 2018 Apr; 70(4):498-506. PubMed ID: 29433156
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.
Lin SP; Hou YC; Liao TY; Tsai SY
Drug Dev Ind Pharm; 2014 Mar; 40(3):330-7. PubMed ID: 23369092
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and in vitro dissolution of magnolol solid dispersion].
Tang L; Qiu SB; Wu L; Lv LF; Lv HX; Shan WG
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):433-437. PubMed ID: 28868859
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
9. Osmotic pump tablets with solid dispersions synergized by hydrophilic polymers and mesoporous silica improve in vitro/in vivo performance of cilostazol.
Zhang S; Sun Y; Zhou L; Jiang Z; Yang X; Feng Y
Int J Pharm; 2020 Oct; 588():119759. PubMed ID: 32800938
[TBL] [Abstract][Full Text] [Related]
10. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
12. The Amorphous Solid Dispersion of Chrysin in Plasdone
Wang C; Liu X; Zhao R; Yang M; Liu W; Dai Q; Bao X; Chen Y; Ma J
Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896138
[TBL] [Abstract][Full Text] [Related]
13. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
14. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
15. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
16. Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique.
Boghra RJ; Kothawade PC; Belgamwar VS; Nerkar PP; Tekade AR; Surana SJ
Chem Pharm Bull (Tokyo); 2011; 59(4):438-41. PubMed ID: 21467670
[TBL] [Abstract][Full Text] [Related]
17. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
18. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
[TBL] [Abstract][Full Text] [Related]
19. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.
Cho Y; Ha ES; Baek IH; Kim MS; Cho CW; Hwang SJ
Molecules; 2015 May; 20(6):9496-509. PubMed ID: 26020699
[TBL] [Abstract][Full Text] [Related]
20. Solid super saturated self-nanoemulsifying drug delivery system (sat-SNEDDS) as a promising alternative to conventional SNEDDS for improvement rosuvastatin calcium oral bioavailability.
Abo Enin HA; Abdel-Bar HM
Expert Opin Drug Deliv; 2016 Nov; 13(11):1513-1521. PubMed ID: 27564321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]